Post on the web: https://www.insiderfinancial.c
Post# of 72446
(Total Views: 328)
Posted On: 06/09/2017 12:37:39 PM
Post on the web:
https://www.insiderfinancial.com/heres-why-ce...ow/124063/
https://www.insiderfinancial.com/heres-why-ce...ow/124063/
Quote:
Cellceutix Corp (OTCMKTS:CTIX) Is A Runner Whichever Way You Look At It
By Chris Sandburg / in Biotech, Momentum & Growth, Momentum Stocks, Stocks / on Friday, 09 Jun 2017 11:02 AM / 0 Comment / 121 views
Regular readers will know that here at Insider Financial we’ve covered Cellceutix Corp (OTCMKTS:CTIX) on a number of occasions and that our long-term thesis on the stock is bullish. Our argument has been, and still is, that the market dramatically undervalues the company at its current pricing and is far from representative of the combined value of its development assets at current stage, never mind the potential for expansion as each progresses along its respective development pathway.
Regular readers will also know that we like to keep tabs on what others are saying about Cellceutix, seeking to add balance to what has proven to be wave after wave of misinformed analysis over the last twelve months and more.
One of the biggest culprits of this sort of misinformed coverage is Adam Feuerstein, who, unfortunately, also happens to have a reasonably large following in the space.
Well, he’s at it again:
Cellceutix $CTIX changes name to… I kid you not… Innovation Pharma $IPIX.
New identity, same
(3)
(0)